Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel evidence for m6A methylation regulators as prognostic biomarkers and FTO as a potential therapeutic target in gastric cancer
Tadanobu Shimura, Raju Kandimalla, Yoshinaga Okugawa, et al.
British Journal of Cancer (2021) Vol. 126, Iss. 2, pp. 228-237
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

m6A modification: recent advances, anticancer targeted drug discovery and beyond
Lijuan Deng, Wei-Qing Deng, Shu-Ran Fan, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 255
METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m6A-dependent manner
Yun-zhang Dai, Yong-da Liu, Jie Li, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 88
YTHDF3 facilitates triple-negative breast cancer progression and metastasis by stabilizing ZEB1 mRNA in an m6A-dependent manner
Yuxiang Lin, Xuan Jin, Qian Nie, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 2, pp. 83-83
Open Access | Times Cited: 42
Small-molecule inhibition of the METTL3/METTL14 complex suppresses neuroblastoma tumor growth and promotes differentiation
Monica Pomaville, Mohansrinivas Chennakesavalu, Pingluan Wang, et al.
Cell Reports (2024) Vol. 43, Iss. 5, pp. 114165-114165
Open Access | Times Cited: 12
Exploring new frontiers: cell surface vimentin as an emerging marker for circulating tumor cells and a promising therapeutic target in advanced gastric Cancer
Heming Li, Yangzhuangzhuang Zhu, Lu Xu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 8
Role of m6A methylation in retinal diseases
Xinyu Zhu, Chuandi Zhou, Shuzhi Zhao, et al.
Experimental Eye Research (2023) Vol. 231, pp. 109489-109489
Closed Access | Times Cited: 17
FTO Sensitizes Oral Squamous Cell Carcinoma to Ferroptosis via Suppressing ACSL3 and GPX4
Ziyi Wang, Hongyu Li, Hongshi Cai, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16339-16339
Open Access | Times Cited: 17
METTL3/16-mediated m6A modification of ZNNT1 promotes hepatocellular carcinoma progression by activating ZNNT1/osteopontin/S100A9 positive feedback loop-mediated crosstalk between macrophages and tumour cells
Huamei Wei, Wenchuan Li, Meng Yang, et al.
Clinical Immunology (2024) Vol. 261, pp. 109924-109924
Closed Access | Times Cited: 7
Bromodomain-Containing Protein 9 Regulates Signaling Pathways and Reprograms the Epigenome in Immortalized Human Uterine Fibroid Cells
Qiwei Yang, Somayeh Vafaei, Ali Falahati, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 905-905
Open Access | Times Cited: 6
Demethylases in tumors and the tumor microenvironment: Key modifiers of N6-methyladenosine methylation
Junchen Guo, Liang Zhao, Meiqi Duan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116479-116479
Open Access | Times Cited: 5
FTO Inhibits Epithelial Ovarian Cancer Progression by Destabilising SNAI1 mRNA through IGF2BP2
Meige Sun, Xiaocui Zhang, Fangfang Bi, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5218-5218
Open Access | Times Cited: 24
KIAA1429 promotes gastric cancer progression by destabilizing RASD1 mRNA in an m6A-YTHDF2-dependent manner
Mengting Ren, Hanghai Pan, Xinxin Zhou, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
METTL3 and METTL14-mediated N6-methyladenosine modification of SREBF2-AS1 facilitates hepatocellular carcinoma progression and sorafenib resistance through DNA demethylation of SREBF2
Xianjian Wu, Min Zeng, Yunyu Wei, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
RNA demethylase FTO participates in malignant progression of gastric cancer by regulating SP1-AURKB-ATM pathway
Xueliang Zeng, Yao Lu, Taohui Zeng, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 4
N6-methyladenosine RNA modification in stomach carcinoma: Novel insights into mechanisms and implications for diagnosis and treatment
Zhengmao Lu, Zhaojie Lyu, Peixin Dong, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 5, pp. 167793-167793
Closed Access
Insight into m 6 A methylation from occurrence to functions
Wenxiu Ru, Xiaoyan Zhang, Binglin Yue, et al.
Open Biology (2020) Vol. 10, Iss. 9
Open Access | Times Cited: 34
Expression profiles of m6A RNA methylation regulators, PD-L1 and immune infiltrates in gastric cancer
Zhiyuan Xu, Qiuli Chen, Lilu Shu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 20
Novel insights into m6A modification of coding and non-coding RNAs in tumor biology: From molecular mechanisms to therapeutic significance
Jinlin Jia, Suwen Wu, Zimo Jia, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 11, pp. 4432-4451
Open Access | Times Cited: 17
A liquid biopsy signature for predicting early recurrence in patients with gastric cancer
Keisuke Okuno, Shuichi Watanabe, Roy S, et al.
British Journal of Cancer (2023) Vol. 128, Iss. 6, pp. 1105-1116
Closed Access | Times Cited: 7
Effects of Helicobacter pylori on the expression of the FTO gene and its biological role in gastric cancer
Shuqin Gui, Qinrong Wang, Liya Bao, et al.
Oncology Letters (2023) Vol. 25, Iss. 4
Open Access | Times Cited: 7
Role of N6-methyladenosine RNA modification in gastric cancer
Siqi Ding, Xue-Ping Zhang, Jun‐Peng Pei, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 7
METTL14 attenuates cancer stemness by suppressing ATF5/WDR74/β‐catenin axis in gastric cancer
Peiling Zhang, Hong Xiang, Qian Peng, et al.
Cancer Science (2024)
Open Access | Times Cited: 2
The m6A reader YTHDC1-mediated lncRNA CTBP1-AS2 m6A modification accelerates cholangiocarcinoma progression
Zhe Jin, Yahui Liu
Heliyon (2023) Vol. 9, Iss. 9, pp. e19816-e19816
Open Access | Times Cited: 6
N6-Methyladenosine-Modified LEAWBIH Drives Hepatocellular Carcinoma Progression through Epigenetically Activating Wnt/β-Catenin Signaling
Huamei Wei, Lizheng Huang, Qi Lu, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 1991-2007
Open Access | Times Cited: 6
m6A modification of AC026356.1 facilitates hepatocellular carcinoma progression by regulating the IGF2BP1-IL11 axis
Huamei Wei, Jinhun Yang, Rongzhou Lu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top